Correlation of serum C-reactive protein level with severity of preeclampsia
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253581Keywords:
Preeclampsia, C-reactive protein, Hypertensive disorders of pregnancy, Inflammation, Biomarkers, Disease severityAbstract
Background: Preeclampsia is a hypertensive disorder unique to pregnancy, characterized by elevated blood pressure and proteinuria after 20 weeks of gestation. It is associated with systemic inflammation and generalized endothelial dysfunction. C-reactive protein (CRP), a sensitive marker of inflammation, has been implicated in the pathophysiology of preeclampsia. This study aims to assess serum CRP levels in preeclamptic women and determine its correlation with disease severity.
Methods: A case-control study was conducted over a two-month period at the department of biochemistry and department of obstetrics and gynaecology, Gauhati medical college and hospital. A total of 60 pregnant women were enrolled-30 preeclamptic patients (15 mild, 15 severe) and 30 normotensive pregnant controls-based on strict inclusion and exclusion criteria. Serum CRP levels were measured using the Vitros 5600 integrated system. Data were analyzed using the independent t test and Pearson’s correlation coefficient. A p<0.05 was considered statistically significant.
Results: The mean serum CRP level in preeclamptic patients was significantly higher (14.63±1.99 mg/l) than in normotensive controls (5.98±1.86 mg/l) (p<0.001). Among the preeclamptic group, severe cases had significantly higher CRP levels (16.23±1.06 mg/l) compared to mild cases (13.03±1.28 mg/l) (p<0.001). CRP levels showed a strong positive correlation with both systolic and diastolic blood pressures (DBP) in both mild (r=0.97 and r=0.98, respectively) and severe (r=0.95 and r=0.93, respectively) preeclampsia groups.
Conclusions: Serum CRP levels are elevated in preeclampsia compared to normal pregnancy and increase further with disease severity.
Metrics
References
Meena ML, Meena K, Meena BS, Gidwani C. Serum C-reactive protein in normal pregnancy and preeclampsia: a comparative study. Int J Clin Obstet Gynaecol. 2019;3(2):141-5. DOI: https://doi.org/10.33545/gynae.2019.v3.i2c.25
American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-60. DOI: https://doi.org/10.1097/AOG.0000000000003891
Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339. DOI: https://doi.org/10.1038/s41598-021-00839-w
Aruna P, Krishnamma M, Ramalingam K, Naidu JN, Prasad M. Study of high sensitive c-reactive protein in preeclampsia. Int J Clin Biochem Res. 2018;5(2):296-300. DOI: https://doi.org/10.18231/2394-6377.2018.0061
Adejumo OA, Okaka EI, Okwuonu CG, Iyawe IO, Odujoko OO. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana Med J. 2016;50(1):31-8. DOI: https://doi.org/10.4314/gmj.v50i1.5
Alamolhoda SH, Yazdkhasti M, Namdari M, Zakariayi SJ, Mirabi P. Association between C-reactive protein and gestational diabetes: a prospective study. J Obstet Gynaecol. 2020;40(3):349-53. DOI: https://doi.org/10.1080/01443615.2019.1631767
Ismael H, Issa A, Hameed B. Serum ferritin and C-reactive protein levels as indicators of severity of preeclampsia. J Pak Med Assoc. 2024;74(2):S274-7. DOI: https://doi.org/10.47391/JPMA-BAGH-16-62
Todorovska I, Dabeski D, Simeonova Krstevska S, Tanturovski M, Jovanovska V, Kondova Topuzovska I. Levels of C-reactive protein in prediction of preeclampsia. Acad Med J. 2024;4(3):52-6. DOI: https://doi.org/10.53582/AMJ2443052t
Ustün Y, Engin-Ustün Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;121(2):154-8. DOI: https://doi.org/10.1016/j.ejogrb.2004.12.009
Shetty SS, Mishra SP, Shafiulla SA. Association of maternal C-reactive protein in severe pre-eclampsia. J Evol Med Dent Sci. 2020;9(28):2002-6. DOI: https://doi.org/10.14260/jemds/2020/436
Bansal P, Shaker IA, Bansal AK, Kaushik G. Assessment of inflammatory markers in preeclampsia. Indian J Med Biochem. 2018;22(2):138-42. DOI: https://doi.org/10.5005/jp-journals-10054-0071
Sayyed AAK, Pratinidhi SA. High sensitive C reactive protein as an inflammatory indicator in preeclampsia. Int J Res Med Sci. 2020;8(8):3002-6. DOI: https://doi.org/10.18203/2320-6012.ijrms20203454
Gharib M, Mostafa M, Harira M, Attia A. Predictive value of maternal serum C-reactive protein levels with severity of preeclampsia. Zagazig Univ Med J. 2016;22(2):1-12. DOI: https://doi.org/10.21608/zumj.2016.4638
Kusuma AANJ, Darmayasa IM, Widiyanti ES, Maharta IGBA. High C-reactive protein serum levels as a risk factor for preeclampsia. Eur J Med Health Sci. 2024;6(4):9-14. DOI: https://doi.org/10.24018/ejmed.2024.6.4.2140
Biswas J, Datta M, Kar K, Mitra D, Jyothi L, Maitra A. Role of serum high-sensitive C-reactive protein to predict severity of pre-eclampsia in a high-population resource-poor country: a prospective observational study. J Rural Med. 2025;20(2):71-7. DOI: https://doi.org/10.2185/jrm.2024-031
Downloads
Published
How to Cite
Issue
Section
